Citations

Mayo Clinic

Showing 10 of 108599 citations.

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
Levink, Iris J. M. , Jaarsma, Sanne, Koopmann, Brechtje D.M. , Riet, Priscilla A. van , Overbeek, Kasper A. , Meziani, Jihane , Sprij, Marloes L. J. A. , Polkowski, Marcin , Engels, Megan , Waaij, Laurens A. van der, Carrara, Silvia , Pando, Elizabeth , Vornhülz, Marlies , Honkoop, Pieter, Schoon, Erik J. , Laukkarinen, Johanna , Bergmann, Jilling F., Rossi, Gemma , Vilsteren, Frederike G.I. van , Berkel, Anne‐Marie van, Tabone, Trevor , Schwartz, Matthijs P. , Tan, Adriaan C.I.T.L. , Soest, Ellert van, Czacko, Laszlo, Bruno, Marco J. , Cahen, Djuna L. , group, the PACYFIC‐registry work, Engels, Megan M L, Quispel, Rutger , Casadei, Riccardo , Ingaldi, Carlo , Bergmann, Jilling F., Hooft, Jeanin E. van , group, the PACYFIC‐registry work

United European Gastroenterology Journal | July 12, 2023 | Volume: 11 | Issue: 7 | Pages: 601-611

10.1002/ueg2.12422 | PMID 37435855 Get It

AbstractBackgroundSurveillance of pancreatic cysts focuses on the detection of (mostly morphologic) features warranting surgery. European guidelines consider elevated CA19.9 as a relative indication for surgery. We aimed to evaluate the role of CA19.9 monitoring for early detection and management in a cyst surveillance population.MethodsThe PACYFIC‐registry is a prospective collaboration that investigates the yield of pancreatic cyst surveillance performed at the discretion of the treating physician. We included participants for whom at least one serum CA19.9 value was determined by a minimum follow‐up of 12 months.ResultsOf 1865 PACYFIC participants, 685 met the inclusion criteria for this study (mean age 67 years, SD 10; 61% female). During a median follow‐up of 25 months (IQR 24, 1966 visits), 29 participants developed high‐grade dysplasia (HGD) or pancreatic cancer. At baseline, CA19.9 ranged from 1 to 591 kU/L (median 10 kU/L [IQR 14]), and was elevated (≥37 kU/L) in 64 participants (9%). During 191 of 1966 visits (10%), an elevated CA19.9 was detected, and these visits more often led to an intensified follow‐up (42%) than those without an elevated CA19.9 (27%; p < 0.001). An elevated CA19.9 was the sole reason for surgery in five participants with benign disease (10%). The baseline CA19.9 value was (as continuous or dichotomous variable at the 37 kU/L threshold) not independently associated with HGD or pancreatic cancer development, whilst a CA19.9 of ≥ 133 kU/L was (HR 3.8, 95% CI 1.1–13, p = 0.03).ConclusionsIn this pancreatic cyst surveillance cohort, CA19.9 monitoring caused substantial harm by shortening surveillance intervals (and performance of unnecessary surgery). The current CA19.9 cutoff was not predictive of HGD and pancreatic cancer, whereas a higher cutoff may decrease false‐positive values. The role of CA19.9 monitoring should be critically appraised prior to implementation in surveillance programs and guidelines.
Bundled Care to Reduce Sepsis Mortality: The Improving Pediatric Sepsis Outcomes (IPSO) Collaborative
Paul, Raina, Niedner, Matthew , Riggs, Ruth , Richardson, Troy , Balamuth, Frances, Campbell, Deborah, Depinet, Holly, Hueschen, Leslie A. , Kandil, Sarah , Larsen, Gitte , Mack, Elizabeth H. , Priebe, Gregory P. , Rutman, Lori , Schafer, Melissa , Scott, Halden F. , Silver, Pete, Stalets, Erika , Wathen, Beth A., Macias, Charles G. , Brilli, Richard J., INVESTIGATORS, for the IPSO COLLABORATIVE, Souza, Heidi G. De , Auletta, Jeffery J. , Balamuth, Fran , Huskins, W. Charles , Silver, Pete, Wathen, Beth, INVESTIGATORS, for the IPSO COLLABORATIVE

Pediatrics | July 12, 2023 | Volume: 152 | Issue: 2 | Pages: No page available

10.1542/peds.2022-059938 | PMID 37435672 Get It

OBJECTIVES We sought to improve utilization of a sepsis care bundle and decrease 3- and 30- day sepsis-attributable mortality, as well as determine which care elements of a sepsis bundle are associated with improved outcomes. METHODS Children’s Hospital Association formed a QI collaborative to Improve Pediatric Sepsis Outcomes (IPSO) (January 2017–March 2020 analyzed here). IPSO Suspected Sepsis (ISS) patients were those without organ dysfunction where the provider “intended to treat” sepsis. IPSO Critical Sepsis (ICS) patients approximated those with septic shock. Process (bundle adherence), outcome (mortality), and balancing measures were quantified over time using statistical process control. An original bundle (recognition method, fluid bolus &lt; 20 min, antibiotics &lt; 60 min) was retrospectively compared with varying bundle time-points, including a modified evidence-based care bundle, (recognition method, fluid bolus &lt; 60 min, antibiotics &lt; 180 min). We compared outcomes using Pearson χ-square and Kruskal Wallis tests and adjusted analysis. RESULTS Reported are 24 518 ISS and 12 821 ICS cases from 40 children’s hospitals (January 2017–March 2020). Modified bundle compliance demonstrated special cause variation (40.1% to 45.8% in ISS; 52.3% to 57.4% in ICS). The ISS cohort’s 30-day, sepsis-attributable mortality dropped from 1.4% to 0.9%, a 35.7% relative reduction over time (P &lt; .001). In the ICS cohort, compliance with the original bundle was not associated with a decrease in 30-day sepsis-attributable mortality, whereas compliance with the modified bundle decreased mortality from 4.75% to 2.4% (P &lt; .01). CONCLUSIONS Timely treatment of pediatric sepsis is associated with reduced mortality. A time-liberalized care bundle was associated with greater mortality reductions.
Chronic pain outcomes of patients receiving electroconvulsive therapy: A systematic review and case series
Yoon, Isabel A. , Galarneau, David, Yoon, Isabel A

Pain Practice | July 12, 2023 | Volume: 23 | Issue: 8 | Pages: 942-955

10.1111/papr.13268 | PMID 37434489 Get It

AbstractIntroductionThe potential benefits of electroconvulsive therapy (ECT) in chronic pain and several theories for its mechanism have been reported in the past, but mixed findings have also been reported. In the current systematic review and case series, our primary aim was to assess whether pain and functional outcomes are improved after ECT in patients with chronic pain. Secondary objectives included examining whether psychiatric improvement, specific pain diagnoses, and demographic or medical characteristics were associated with differences in pain treatment response.MethodsWe performed a retrospective chart review to identify patients with chronic pain diagnoses for more than 3 months prior to the initiation of ECT and a systematic literature search on electronic databases for studies on chronic pain outcomes after ECT.ResultsEleven patients with various chronic pain diagnoses and comorbid psychiatric conditions were identified in the case series. Six patients reported improvement in pain while 10 patients reported improvement in mood following ECT. Systematic review identified 22 articles reporting a total of 109 cases. Eighty‐five (78%) of cases reported reduction in pain while 96.3% of the patients with a comorbid psychiatric diagnosis reported improvement in mood symptoms post‐ECT. While there was an association between improvement in mood and pain in studies with numeric ratings in both outcomes (r = 0.61; p < 0.001), some patients reported pain improvement without improvement in mood in both the case series and the pooled analysis of cases in the review. Certain pain diagnoses such as CRPS, phantom limb pain, neuropathic pain, and low back pain have consistently reported benefits and should be further studied in future studies with matched case controls.ConclusionECT may be offered to patients with certain pain conditions who have not responded sufficiently to conventional therapies, particularly when comorbid mood symptoms are present. Improved documentation practices on the outcomes in chronic pain patients receiving ECT will help generate more studies that are needed on this topic.
Statistical Considerations and Software for Designing Sequential, Multiple Assignment, Randomized Trials (SMART) with a Survival Final Endpoint
Kravets, Sasha , Ruppert, Amy S. , Mandrekar, Sumithra J. , Jacobson, Sawyer B, Jacobson, Sawyer , Le‐Rademacher, Jennifer

Journal of Biopharmaceutical Statistics | July 12, 2023 | Volume: 34 | Issue: 4 | Pages: 539-552

10.1080/10543406.2023.2233616 | PMID 37434437 Get It

A nitroalkene derivative of salicylate alleviates diet-induced obesity by activating creatine metabolism and non-shivering thermogenesis
Cal, Karina, Leyva, Alejandro , Rodriguez-Duarte, Jorge, Ruiz, Santiago , Santos, Leonardo, Colella, Lucía, Ingold, Mariana , Vilaseca, Cecilia, Galliussi, Germán , Handy, Rachel, Reis, Larissa Menezes dos , Espasandín, Camila , Dapueto, Rosina , Thompson, Katie, Agorrody, Guillermo , DeVallance, Evan , Meadows, Ethan , Barbosa, Gabriele Santana, Souza, Leonardo Osbourne Lai de , Chichierchio, Marina Santos , Valez, Valeria , Aicardo, Adrián , Jakobsen, Steen, Kamaid, Andrés , Porcal, Williams , Calliari, Aldo , Wang, Yekai, Hollander, John M. , White, Thomas A. , Radí, Rafael , O’Doherty, Robert M. , Holloway, Graham P. , Kelley, Eric, Chini, Eduardo N. , Peclat, Thais R , Dos Reis, Larissa Menezes , Thompson, Katie L., Chichierchio, Marina Santos , Aicardo, Adrián , Contreras, Paola , White, Thomas A , Quijano, Celia , Moraes-Vieira, Pedro , Mori, Marcelo A , Lopez, Gloria V , Batthyány, Carlos , Chini, Eduardo Nunes , Escande, Carlos , Rodriguez‐Duarte, Jorge , Ziegler, Lucía , Peclat, Thais , Bresque, Mariana , Handy, Rachel, King, Rachel, Breining, Peter , Lopez, Andres, Lewis, Sara E. , Vendelbo, Mikkel Holm , Verdes, José Manuel , Du, Jianhai , Moyna, Guillermo , Leonardi, Roberta , Camacho-Pereira, Juliana , Durán, Rosario

No container title available | July 12, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3101395/v1 | PMID 37502859 Get It

Abstract Obesity-related type II diabetes (diabesity) has increased global morbidity and mortality dramatically. Previously, the ancient drug salicylate demonstrated promise for the treatment of type II diabetes, but its clinical use was precluded due to high dose requirements. In this study, we present a nitroalkene derivative of salicylate, 5-(2-nitroethenyl)salicylic acid (SANA), a molecule with unprecedented beneficial effects in diet-induced obesity (DIO). SANA reduces DIO, liver steatosis and insulin resistance at doses up to 40 times lower than salicylate. Mechanistically, SANA stimulated mitochondrial respiration and increased creatine-dependent energy expenditure in adipose tissue. Indeed, depletion of creatine resulted in the loss of SANA action. Moreover, we found that SANA binds to creatine kinases CKMT1/2, and downregulation CKMT1 interferes with the effect of SANA in vivo. Together, these data demonstrate that SANA is a first-in-class activator of creatine-dependent energy expenditure and thermogenesis in adipose tissue and emerges as a candidate for the treatment of diabesity.
An Unusual Presentation of Pediatric Gastrointestinal Stromal Tumor
Cárdenas, María C. , Hamel, Benjamin , Weckwerth, Jody , Potter, Dean, Bofill-Garcia, Aliana M., Schwartz, Jonathan , Hassan, Sara , Gonzalez, Michelle , Cardenas, Maria Camila, Hassan, Sara, Storm, Andrew C.

Journal of Pediatric Gastroenterology and Nutrition | July 12, 2023 | Volume: 77 | Issue: 5 | Pages: No page available

10.1097/mpg.0000000000003888 | PMID 37434284 Get It

Nonoperative Management of Degenerative Medial Meniscus Posterior Root Tears: Poor Outcomes at a Minimum 10-Year Follow-up
Krych, Aaron J. , Lamba, Abhinav , Wang, Allen S. , Boos, Alexander M. , Camp, Christopher L. , Levy, Bruce A. , Stuart, Michael J. , Camp, Christopher L. , Krych, Aaron J , Stuart, Michael J , Wang, Allen , Lamba, Abhinav , Boos, Alexander , Hevesi, Mario

The American Journal of Sports Medicine | July 12, 2023 | Volume: 51 | Issue: 10 | Pages: 2603-2607

10.1177/03635465231185132 | PMID 37434486 Get It

Background: Medial meniscus posterior root tears (MMPRTs) cause pain and dysfunction and are associated with poor clinical outcomes with nonoperative management at short-term follow-up. However, little is known about the long-term natural history of these tears. Purpose: The purpose of this study was to (1) provide an update to a previous minimum 2-year study on the natural progression of these tears and (2) evaluate long-term patient-reported and radiographic outcomes. Study Design: Case series (prognosis); Level of evidence, 4. Methods: A retrospective review was performed on a cohort of patients with untreated MMPRTs, diagnosed between 2005 and 2013, who were followed clinically using International Knee Documentation Committee (IKDC), visual analog scale for pain, and Tegner activity scores as well as radiographically at a minimum 10-year follow-up. Failure was defined as conversion to arthroplasty or a severely abnormal subjective IKDC score <75.4. Results: Overall, 5 (10%) of the original 52 patients with minimum 2-year outcomes were subsequently lost to follow-up. The remaining 47 patients (21 male, 26 female) were followed for a mean of 14 ± 2 years (range, 11-18 years). At final follow-up, 25 patients (53%) had progressed to total knee arthroplasty, 8 (17%) were deceased, and 14 (30%) had not progressed to total knee arthroplasty. The mean IKDC and Tegner activity scores for the 14 patients with remaining MMPRTs were 51.6 ± 22.2 and 3.1 ± 1.1, respectively, and the mean visual analog scale score was 4.4 ± 3.0. Radiographically, the mean Kellgren-Lawrence grade progressed from 1.2 ± 0.7 at baseline to 2.6 ± 0.5 at final follow-up ( P < .001). At a minimum 10-year follow-up, 37 of 39 living patients (95%) had failed nonoperative treatment. Conclusion: Poor clinical and radiographic outcomes were associated with the nonoperative treatment of degenerative MMPRTs at long-term follow-up. This study provides a valuable update on the natural history and long-term prognosis of nonoperatively treated MMPRTs.
Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks
Vahdat, Vahab , Alagöz, Oğuzhan , Chen, Jing Voon , Saoud, Leila, Vahdat, Vahab , Borah, Bijan J. , Limburg, Paul J.

Medical Decision Making | July 12, 2023 | Volume: 43 | Issue: 6 | Pages: 719-736

10.1177/0272989x231184175 | PMID 37434445 Get It

Objectives Machine learning (ML)–based emulators improve the calibration of decision-analytical models, but their performance in complex microsimulation models is yet to be determined. Methods We demonstrated the use of an ML-based emulator with the Colorectal Cancer (CRC)-Adenoma Incidence and Mortality (CRC-AIM) model, which includes 23 unknown natural history input parameters to replicate the CRC epidemiology in the United States. We first generated 15,000 input combinations and ran the CRC-AIM model to evaluate CRC incidence, adenoma size distribution, and the percentage of small adenoma detected by colonoscopy. We then used this data set to train several ML algorithms, including deep neural network (DNN), random forest, and several gradient boosting variants (i.e., XGBoost, LightGBM, CatBoost) and compared their performance. We evaluated 10 million potential input combinations using the selected emulator and examined input combinations that best estimated observed calibration targets. Furthermore, we cross-validated outcomes generated by the CRC-AIM model with those made by CISNET models. The calibrated CRC-AIM model was externally validated using the United Kingdom Flexible Sigmoidoscopy Screening Trial (UKFSST). Results The DNN with proper preprocessing outperformed other tested ML algorithms and successfully predicted all 8 outcomes for different input combinations. It took 473 s for the trained DNN to predict outcomes for 10 million inputs, which would have required 190 CPU-years without our DNN. The overall calibration process took 104 CPU-days, which included building the data set, training, selecting, and hyperparameter tuning of the ML algorithms. While 7 input combinations had acceptable fit to the targets, a combination that best fits all outcomes was selected as the best vector. Almost all of the predictions made by the best vector laid within those from the CISNET models, demonstrating CRC-AIM’s cross-model validity. Similarly, CRC-AIM accurately predicted the hazard ratios of CRC incidence and mortality as reported by UKFSST, demonstrating its external validity. Examination of the impact of calibration targets suggested that the selection of the calibration target had a substantial impact on model outcomes in terms of life-year gains with screening. Conclusions Emulators such as a DNN that is meticulously selected and trained can substantially reduce the computational burden of calibrating complex microsimulation models. Highlights Calibrating a microsimulation model, a process to find unobservable parameters so that the model fits observed data, is computationally complex. We used a deep neural network model, a popular machine learning algorithm, to calibrate the Colorectal Cancer Adenoma Incidence and Mortality (CRC-AIM) model. We demonstrated that our approach provides an efficient and accurate method to significantly speed up calibration in microsimulation models. The calibration process successfully provided cross-model validation of CRC-AIM against 3 established CISNET models and also externally validated against a randomized controlled trial.
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis
Rogen, Kara R., Iyyangar, Anushka, Schnell, R., Mitchell, Jessica L. , Hubbard, Joleen M. , Jatoi, Aminah , Shi, Qian , Jin, Zhaohui , Iyyangar, Anushka , Schnell, Rylie R, Hubbard, Joleen , Jin, Zhaohui , Shi, Qian , Storandt, Michael H. , Rogen, Kara , Schnell, Rylie R., Sinicrope, Frank A. , Mahipal, Amit

Cancers | July 12, 2023 | Volume: 15 | Issue: 14 | Pages: 3570

10.3390/cancers15143570 | PMID 37509234 Get It

Over the past 20 years, rates of early-onset colorectal cancer (eoCRC), defined as <50 years of age at diagnosis, have increased, with 16–25% associated with a pathogenic germline variant (PGV) resulting in a hereditary cancer syndrome. In the present study, we sought to further characterize PGVs observed in patients with eoCRC. We conducted a retrospective analysis of patients with a history of CRC referred for genetic counseling at Mayo Clinic Rochester between April 2019 and April 2022. Three hundred and three CRC patients were referred to medical genetics, including 124 with a history of eoCRC. Only 84 patients (68%) with eoCRC referred for genetic counseling completed genetic testing, with an average of 48 genes evaluated. PGVs were identified in 27.4% with eoCRC, including 8.3% with Lynch syndrome (LS). Other detected PGVs known to increase the risk of CRC included MUTYH (4.8%), CHEK2 (3.6%), APC, BMPR1A, and TP53 (1.3% each). Among those with aoCRC, 109 patients (61%) completed genetic testing, among which 88% had either a dMMR tumor, personal history of an additional LS malignancy, or family history of LS malignancy, with PGVs detected in 23% of patients. This study reinforces the importance for all patients with CRC, especially those with eoCRC, to undergo germline testing.
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis
Chesdachai, Supavit , Lahr, Brian D. , Vege, Santhi Swaroop , Vergidis, Paschalis , Vergidis, Paschalis , Chesdachai, Supavit , Yetmar, Zachary A.

Medical Mycology | July 12, 2023 | Volume: 61 | Issue: 7 | Pages: No page available

10.1093/mmy/myad068 | PMID 37433581 Get It

Abstract Pancreatic fungal infection (PFI) in patients with necrotizing pancreatitis can lead to significant morbidity and mortality. The incidence of PFI has increased during the past decade. Our study aimed to provide contemporary observations on the clinical characteristics and outcomes of PFI in comparison to pancreatic bacterial infection and necrotizing pancreatitis without infection. We conducted a retrospective study of patients with necrotizing pancreatitis (acute necrotic collection or walled-off necrosis), who underwent pancreatic intervention (necrosectomy and/or drainage) and had tissue/fluid culture between 2005 and 2021. We excluded patients with pancreatic procedures prior to hospitalization. Multivariable logistic and Cox regression models were fitted for in-hospital and 1-year survival outcomes. A total of 225 patients with necrotizing pancreatitis were included. Pancreatic fluid and/or tissue was obtained from endoscopic necrosectomy and/or drainage (76.0%), CT-guided percutaneous aspiration (20.9%), or surgical necrosectomy (3.1%). Nearly half of the patients had PFI with or without concomitant bacterial infection (48.0%), while the remaining patients had either bacterial infection alone (31.1%) or no infection (20.9%). In multivariable analysis to assess the risk of PFI or bacterial infection alone, only previous pancreatitis was associated with an increased odds of PFI vs. no infection (OR 4.07, 95% CI 1.13-14.69, p = .032). Multivariable regression analyses revealed no significant differences in in-hospital outcomes or one-year survival between the 3 groups. Pancreatic fungal infection occurred in nearly half of necrotizing pancreatitis. Contrary to many of the previous reports, there was no significant difference in important clinical outcomes between the PFI group and each of the other two groups.